US EditionQ2 EPS Estimate for Quest Diagnostics Increased by Analyst
Summary by ETF Daily News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Q2 EPS Estimate for Quest Diagnostics Increased by Analyst
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Equities research analysts at Zacks Research boosted their Q2 2025 earnings per share estimates for shares of Quest Diagnostics in a report issued on Tuesday, May 13th. Zacks Research analyst R. Department now expects that the medical research company will post earnings of $2.55 per share for […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
